{"gene":"CEACAM8","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1996,"finding":"CD66b (CEACAM8) antibody binding to neutrophils triggers a transient calcium-dependent activation signal that upregulates CD11/CD18 surface expression and increases neutrophil adhesion to endothelial cells; the signal requires extracellular calcium at or near the time of antibody binding and is blocked by anti-CD18 antibody.","method":"Neutrophil adhesion assay to HUVEC monolayers, anti-CD66 mAb stimulation, calcium chelation, flow cytometry","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 — clean functional assay with multiple blocking controls, single lab","pmids":["8699114"],"is_preprint":false},{"year":1996,"finding":"CD66b (CGM6) and CD66c (NCA) mediate heterophilic cell adhesion via interaction between their N-terminal domains; deglycosylated forms retain adhesion activity, indicating carbohydrate portions are not required for binding. Primed neutrophil binding to immobilized CD66b or CD66c induces superoxide anion release.","method":"Recombinant protein binding assay (CHO transfectants expressing CD66b/CD66c), deglycosylation, N-domain blocking with anti-CD66 mAbs, superoxide assay","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with recombinant proteins, mutagenesis-equivalent domain blocking, functional readout","pmids":["8645267"],"is_preprint":false},{"year":1999,"finding":"CD66b (100 kDa) is identified as a major galectin-3 receptor on neutrophils; it is stored in gelatinase and specific granules of resting neutrophils and mobilized to the cell surface upon activation. Galectin-3 binding activity was demonstrated by affinity chromatography on galectin-3-Sepharose.","method":"Galectin-3-Sepharose affinity chromatography of neutrophil granule fractions, immunoblotting, subcellular fractionation, HL-60 differentiation model","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — affinity purification from native granules plus functional validation with HL-60 model lacking CD66","pmids":["10553088"],"is_preprint":false},{"year":1999,"finding":"CD66b cross-linking on neutrophils induces redistribution and clustering of CD11b (CD11b/CD18) on the neutrophil surface via a lectin-like interaction sensitive to D-mannose inhibition; this CD66b–CD11b/CD18 cooperation is required for GM-CSF/Lym-1-mediated neutrophil cytolytic activity.","method":"Immunofluorescence co-staining of CD66b and CD11b after cross-linking, D-mannose inhibition, anti-CD18 blocking, cytolysis assay with blocking antibodies","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — direct imaging of co-redistribution plus multiple functional blocking experiments, single lab","pmids":["10233903"],"is_preprint":false},{"year":2001,"finding":"CEACAM8 (CD66b) exhibits only heterophilic adhesion to CEACAM6, not homophilic adhesion. The N-terminal domain of CEACAM8 on one cell binds the N-domain of CEACAM6 on the opposing cell. Homologue-scanning mutagenesis of CEACAM6 showed that critical adhesion residues for CEACAM6–CEACAM8 heterophilic interaction overlap with but are not identical to those for CEACAM6 homophilic adhesion.","method":"CHO transfectants expressing mutant/chimeric CEACAM6 and CEACAM8 proteins, homologue-scanning mutagenesis, cell adhesion assay","journal":"Journal of leukocyte biology","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with cell-based adhesion readout, multiple mutants tested","pmids":["11590190"],"is_preprint":false},{"year":2006,"finding":"Cross-linking of CD66b on neutrophils induces directed release of preformed interleukin-8 (IL-8) from intracellular storage without de novo cytokine synthesis, in contrast to LPS which induces de novo synthesis.","method":"CD66b mAb cross-linking of human neutrophils, intracellular IL-8 detection, comparison with LPS stimulation, ELISA","journal":"Human immunology","confidence":"Medium","confidence_rationale":"Tier 2 — clean KD/stimulation with defined phenotypic readout distinguishing two activation modes, single lab","pmids":["17002897"],"is_preprint":false},{"year":2007,"finding":"CD66b engagement on eosinophils by mAb or its natural ligand galectin-3 activates the Src kinase family member Hck and induces cellular adhesion, superoxide production, and degranulation. CD66b localizes in lipid rafts; disruption of lipid rafts or removal of the GPI anchor inhibits eosinophil activation. CD66b is constitutively associated with the beta2 integrin CD11b, and CD66b cross-linking induces striking clustering of CD11b.","method":"mAb and galectin-3 stimulation of eosinophils, Hck activation assay, lipid raft disruption (methyl-beta-cyclodextrin), GPI anchor removal (PI-PLC), co-immunoprecipitation of CD66b with CD11b, immunofluorescence microscopy","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (co-IP, lipid raft disruption, PI-PLC, kinase assay, imaging) in single study","pmids":["18056392"],"is_preprint":false},{"year":1992,"finding":"CD66b (NCA-95/CGM6) is a GPI-anchored glycoprotein; it is released from the granulocyte cell surface by phosphatidylinositol-specific phospholipase C, confirming GPI anchorage. Its deglycosylated core is ~38 kDa.","method":"PI-PLC treatment of granulocytes, SDS-PAGE, immunoblotting with anti-CD67 antibody, deglycosylation","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 — direct enzymatic GPI cleavage with biochemical confirmation","pmids":["1370882"],"is_preprint":false},{"year":1998,"finding":"The CGM6 gene (encoding CD66b/CEACAM8) contains all cis-regulatory elements required for granulocyte-specific expression within a 16.5 kb cosmid region spanning 6 exons; CD66b expression begins in fetal liver at day 12.5 and appears in bone marrow at day 17.5 in transgenic mice, and is exclusive to granulocytes in adult bone marrow and spleen.","method":"Transgenic mouse model with human CGM6 cosmid, Northern blot, immunohistochemistry, FACScan analysis","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo transgenic model with multiple tissue readouts, single lab","pmids":["9427723"],"is_preprint":false},{"year":2014,"finding":"Soluble CEACAM8 (released by granulocytes in response to bacterial DNA via TLR9-dependent signaling) binds to CEACAM1 on pulmonary epithelial cells, leading to tyrosine phosphorylation of the CEACAM1 ITIM, recruitment of the phosphatase SHP-1, and consequent inhibition of TLR2-dependent PI3K-Akt pathway activation and pro-inflammatory responses.","method":"CEACAM8-Fc recombinant protein binding to CEACAM1+ epithelial cells, co-IP/pulldown, phospho-ITIM detection, SHP-1 recruitment assay, TLR2 stimulation assay with PI3K-Akt readout, BALF analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 — recombinant protein interaction, signaling pathway dissection with ITIM phosphorylation and phosphatase recruitment, in vitro and ex vivo validation","pmids":["24743304"],"is_preprint":false},{"year":2019,"finding":"Extracellular chromatin (including mono-nucleosomes and long chromatin fragments) triggers secretion of soluble CEACAM8 by primary human PMN in a time- and concentration-dependent manner, involving both de novo synthesis and degranulation-mediated release; CEACAM8 was also detected at high concentration in synovial fluid of RA patients.","method":"Primary human PMN stimulation with chromatin/nucleosomes, ELISA for soluble CEACAM8, inhibitor studies distinguishing synthesis vs. degranulation, synovial fluid analysis","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 — direct stimulation with natural ligand, two mechanistic pathways distinguished, single lab","pmids":["31258530"],"is_preprint":false}],"current_model":"CEACAM8 (CD66b) is a GPI-anchored, granulocyte-specific glycoprotein stored in specific and gelatinase granules that, upon mobilization to the cell surface, functions as a galectin-3 receptor and heterophilic adhesion molecule (binding CEACAM6 via N-domain interactions); its engagement activates Src-family kinase Hck, induces CD11b clustering through constitutive physical association, triggers calcium-dependent upregulation of CD11/CD18-mediated adhesion, and drives degranulation including release of preformed IL-8; in its soluble secreted form (released via TLR9-dependent signaling or in response to extracellular chromatin), CEACAM8 binds CEACAM1 on epithelial cells, phosphorylates the CEACAM1 ITIM, recruits SHP-1, and dampens TLR2-dependent PI3K-Akt pro-inflammatory signaling."},"narrative":{"teleology":[{"year":1992,"claim":"Establishing that CEACAM8 is GPI-anchored resolved how a CEA-family member lacking a transmembrane domain is tethered to the granulocyte surface and set the stage for understanding its signaling through lipid-raft-associated partners rather than an intrinsic cytoplasmic tail.","evidence":"PI-PLC cleavage from granulocytes with SDS-PAGE/immunoblot confirmation of released ~38 kDa deglycosylated core","pmids":["1370882"],"confidence":"Medium","gaps":["Mechanism by which a GPI-anchored protein without a cytoplasmic domain transduces signals was unknown","Whether GPI anchorage was required for function in vivo was untested"]},{"year":1996,"claim":"Demonstrating that CEACAM8 engagement triggers calcium-dependent upregulation of CD11/CD18-mediated neutrophil adhesion to endothelium, and that CEACAM8 mediates heterophilic binding with CEACAM6 via N-terminal domains, established its dual role as an adhesion molecule and activation receptor on granulocytes.","evidence":"Anti-CD66b mAb stimulation of neutrophils with HUVEC adhesion assay plus calcium chelation/CD18 blocking; recombinant protein binding assays with CHO transfectants and N-domain blocking antibodies","pmids":["8699114","8645267"],"confidence":"High","gaps":["The downstream kinase signaling pathway was unidentified","Physical association between CEACAM8 and integrins was not yet demonstrated"]},{"year":1998,"claim":"Identifying that all cis-regulatory elements for granulocyte-restricted expression reside within a 16.5 kb CGM6 cosmid explained the lineage-specific expression pattern and showed that CEACAM8 expression begins during fetal hematopoiesis.","evidence":"Transgenic mice carrying human CGM6 cosmid, with Northern blot, immunohistochemistry, and FACS confirming granulocyte-restricted expression from fetal day 12.5","pmids":["9427723"],"confidence":"Medium","gaps":["Specific transcription factors driving granulocyte-restricted expression were not identified","Regulatory elements were not mapped to individual promoter/enhancer regions"]},{"year":1999,"claim":"Identifying CEACAM8 as a major galectin-3 receptor stored in gelatinase and specific granules, and showing that its cross-linking induces CD11b clustering via a mannose-sensitive lectin-like interaction, connected granule mobilization to integrin-dependent effector functions.","evidence":"Galectin-3-Sepharose affinity chromatography of neutrophil granule fractions; immunofluorescence of CD66b/CD11b co-redistribution after cross-linking with D-mannose inhibition","pmids":["10553088","10233903"],"confidence":"High","gaps":["Whether galectin-3 binding directly triggers CD11b clustering or acts through an intermediate was unclear","Nature of the CD66b–CD11b physical interaction was unresolved"]},{"year":2001,"claim":"Systematic mutagenesis established that CEACAM8 engages exclusively in heterophilic (not homophilic) adhesion with CEACAM6, with critical contact residues in the N-domain overlapping but distinct from those used in CEACAM6 homophilic binding, defining the structural basis of selectivity.","evidence":"Homologue-scanning mutagenesis of CEACAM6 in CHO transfectants paired with CEACAM8-expressing cells in cell adhesion assays","pmids":["11590190"],"confidence":"High","gaps":["No crystal structure of the CEACAM8–CEACAM6 N-domain complex","Functional consequence of heterophilic vs. homophilic preference in vivo was untested"]},{"year":2006,"claim":"Showing that CEACAM8 cross-linking triggers directed release of preformed IL-8 without de novo synthesis revealed a rapid, degranulation-coupled cytokine mobilization pathway distinct from transcription-dependent inflammatory responses.","evidence":"CD66b mAb cross-linking of human neutrophils with intracellular IL-8 detection by ELISA, compared to LPS-induced de novo synthesis","pmids":["17002897"],"confidence":"Medium","gaps":["Signaling intermediates linking CD66b engagement to IL-8 granule exocytosis were not identified","Whether this pathway operates in vivo during infection was untested"]},{"year":2007,"claim":"Demonstrating that CEACAM8 resides in lipid rafts, is constitutively associated with CD11b, and signals through Hck upon engagement by galectin-3 provided the missing signaling mechanism for a GPI-anchored protein lacking an intrinsic cytoplasmic domain.","evidence":"Co-immunoprecipitation of CD66b with CD11b, Hck kinase activation assay, lipid raft disruption with methyl-β-cyclodextrin, GPI removal by PI-PLC, immunofluorescence in eosinophils","pmids":["18056392"],"confidence":"High","gaps":["Whether Hck activation is direct or requires an adaptor bridging CD66b to intracellular kinases was unresolved","Structural basis of the constitutive CD66b–CD11b association was unknown"]},{"year":2014,"claim":"Discovering that soluble CEACAM8 binds epithelial CEACAM1, phosphorylates its ITIM, recruits SHP-1, and suppresses TLR2-PI3K-Akt signaling established a granulocyte-derived anti-inflammatory paracrine circuit—the first defined function for the secreted form of CEACAM8.","evidence":"CEACAM8-Fc binding to CEACAM1+ epithelial cells, co-IP for SHP-1 recruitment, phospho-ITIM detection, TLR2/PI3K-Akt pathway analysis, BALF validation","pmids":["24743304"],"confidence":"High","gaps":["Whether soluble CEACAM8 binds CEACAM1 in the same N-domain orientation as cell-surface heterophilic interactions was unknown","In vivo relevance of this anti-inflammatory circuit in infection resolution was not tested in animal models"]},{"year":2019,"claim":"Identifying extracellular chromatin as a stimulus for soluble CEACAM8 secretion (via both degranulation and de novo synthesis) linked sterile inflammation and NETosis to the CEACAM8-mediated anti-inflammatory pathway, and elevated synovial fluid levels in RA patients implied clinical relevance.","evidence":"Primary PMN stimulation with mono-nucleosomes and long chromatin, ELISA, inhibitor dissection of synthesis vs. degranulation, RA synovial fluid analysis","pmids":["31258530"],"confidence":"Medium","gaps":["Receptor or sensor on neutrophils mediating chromatin-induced CEACAM8 release was not identified","Whether elevated soluble CEACAM8 in RA fluid is protective or a disease biomarker was not established","Single-lab finding; independent replication of chromatin-triggered secretion pathway needed"]},{"year":null,"claim":"Key unresolved questions include the structural basis of the CEACAM8–CD11b constitutive complex, the adaptor mechanism linking GPI-anchored CEACAM8 to Hck activation, the in vivo role of the soluble CEACAM8–CEACAM1 anti-inflammatory axis during infection, and the chromatin-sensing pathway that triggers CEACAM8 release.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of the CEACAM8–CD11b or CEACAM8–CEACAM6 complex","No genetic loss-of-function model (CEACAM8 is absent in rodents except as a transgene)","Adaptor linking GPI-anchored CEACAM8 to intracellular kinase Hck is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[1,4]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,6,9]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,6,7]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[2]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[9,10]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,5,6,9]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,9]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[1,4]}],"complexes":[],"partners":["CEACAM6","CEACAM1","LGALS3","ITGAM","HCK","PTPN6"],"other_free_text":[]},"mechanistic_narrative":"CEACAM8 (CD66b) is a GPI-anchored, granulocyte-specific glycoprotein that functions as both a cell-surface adhesion/activation receptor and a soluble anti-inflammatory mediator. Stored in specific and gelatinase granules of resting neutrophils, CEACAM8 is mobilized to the cell surface upon activation, where it serves as a galectin-3 receptor and mediates heterophilic adhesion with CEACAM6 through N-terminal domain interactions; its cross-linking activates the Src-family kinase Hck within lipid rafts, induces clustering of the constitutively associated β2-integrin CD11b/CD18, triggers calcium-dependent upregulation of integrin-mediated adhesion, superoxide production, degranulation, and directed release of preformed IL-8 [PMID:8699114, PMID:8645267, PMID:10553088, PMID:11590190, PMID:18056392, PMID:17002897]. In its soluble form, released via TLR9-dependent signaling in response to bacterial DNA or extracellular chromatin, CEACAM8 binds CEACAM1 on pulmonary epithelial cells, phosphorylates the CEACAM1 ITIM, recruits the phosphatase SHP-1, and thereby dampens TLR2-dependent PI3K-Akt pro-inflammatory signaling [PMID:24743304, PMID:31258530]. Granulocyte-restricted expression is directed by cis-regulatory elements within the CGM6 locus, with expression initiating in fetal liver hematopoiesis [PMID:9427723]."},"prefetch_data":{"uniprot":{"accession":"P31997","full_name":"Cell adhesion molecule CEACAM8","aliases":["CD67 antigen","Carcinoembryonic antigen CGM6","Carcinoembryonic antigen-related cell adhesion molecule 8","CEA cell adhesion molecule 8","Non-specific cross-reacting antigen NCA-95"],"length_aa":349,"mass_kda":38.2,"function":"Cell surface glycoprotein that plays a role in cell adhesion in a calcium-independent manner (PubMed:11590190, PubMed:2022629, PubMed:8776764). Mediates heterophilic cell adhesion with other carcinoembryonic antigen-related cell adhesion molecules, such as CEACAM6 (PubMed:11590190, PubMed:2022629, PubMed:8776764). Heterophilic interaction with CEACAM8 occurs in activated neutrophils (PubMed:8776764)","subcellular_location":"Cell membrane; Cell surface","url":"https://www.uniprot.org/uniprotkb/P31997/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CEACAM8","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CEACAM8","total_profiled":1310},"omim":[{"mim_id":"615747","title":"CEA CELL ADHESION MOLECULE 8; CEACAM8","url":"https://www.omim.org/entry/615747"},{"mim_id":"163980","title":"CEA CELL ADHESION MOLECULE 6; CEACAM6","url":"https://www.omim.org/entry/163980"},{"mim_id":"114890","title":"CEA CELL ADHESION MOLECULE 5; CEACAM5","url":"https://www.omim.org/entry/114890"},{"mim_id":"109770","title":"CEA CELL ADHESION MOLECULE 1; CEACAM1","url":"https://www.omim.org/entry/109770"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"bone marrow","ntpm":204.8}],"url":"https://www.proteinatlas.org/search/CEACAM8"},"hgnc":{"alias_symbol":["CD66b"],"prev_symbol":["CGM6"]},"alphafold":{"accession":"P31997","domains":[{"cath_id":"2.60.40.10","chopping":"38-142","consensus_level":"high","plddt":97.0019,"start":38,"end":142},{"cath_id":"2.60.40.10","chopping":"149-226","consensus_level":"high","plddt":95.5772,"start":149,"end":226},{"cath_id":"2.60.40.10","chopping":"242-320","consensus_level":"high","plddt":96.5025,"start":242,"end":320}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P31997","model_url":"https://alphafold.ebi.ac.uk/files/AF-P31997-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P31997-F1-predicted_aligned_error_v6.png","plddt_mean":86.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CEACAM8","jax_strain_url":"https://www.jax.org/strain/search?query=CEACAM8"},"sequence":{"accession":"P31997","fasta_url":"https://rest.uniprot.org/uniprotkb/P31997.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P31997/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P31997"}},"corpus_meta":[{"pmid":"21953630","id":"PMC_21953630","title":"Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer.","date":"2011","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21953630","citation_count":147,"is_preprint":false},{"pmid":"8699114","id":"PMC_8699114","title":"CD66a, CD66b, CD66c, and CD66d each independently stimulate neutrophils.","date":"1996","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/8699114","citation_count":120,"is_preprint":false},{"pmid":"18056392","id":"PMC_18056392","title":"CD66b regulates adhesion and activation of human eosinophils.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18056392","citation_count":96,"is_preprint":false},{"pmid":"10553088","id":"PMC_10553088","title":"Identification of CD66a and CD66b as the major galectin-3 receptor candidates in human neutrophils.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10553088","citation_count":92,"is_preprint":false},{"pmid":"10520185","id":"PMC_10520185","title":"Enhanced expression of integrins and CD66b on peripheral blood neutrophils and eosinophils in patients with rheumatoid arthritis, and the effect of glucocorticoids.","date":"1999","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10520185","citation_count":61,"is_preprint":false},{"pmid":"35484408","id":"PMC_35484408","title":"CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors.","date":"2022","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35484408","citation_count":54,"is_preprint":false},{"pmid":"24743304","id":"PMC_24743304","title":"Soluble CEACAM8 interacts with CEACAM1 inhibiting TLR2-triggered immune responses.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24743304","citation_count":48,"is_preprint":false},{"pmid":"11590190","id":"PMC_11590190","title":"Identification and comparison of residues critical for cell-adhesion activities of two neutrophil CD66 antigens, CEACAM6 and CEACAM8.","date":"2001","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/11590190","citation_count":46,"is_preprint":false},{"pmid":"17002897","id":"PMC_17002897","title":"Crosslinking of CD66B on peripheral blood neutrophils mediates the release of interleukin-8 from intracellular storage.","date":"2006","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17002897","citation_count":41,"is_preprint":false},{"pmid":"7614736","id":"PMC_7614736","title":"Increased synovial expression of the adhesion molecules CD66a, CD66b, and CD31 in rheumatoid and osteoarthritis.","date":"1995","source":"Clinical immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/7614736","citation_count":39,"is_preprint":false},{"pmid":"22319104","id":"PMC_22319104","title":"CD66b overexpression and homotypic aggregation of human peripheral blood neutrophils after activation by a gram-positive stimulus.","date":"2012","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/22319104","citation_count":37,"is_preprint":false},{"pmid":"1370882","id":"PMC_1370882","title":"Three different NCA species, CGM6/CD67, NCA-95, and NCA-90, are comprised in the major 90 to 100-kDa band of granulocyte NCA detectable upon SDS-polyacrylamide gel electrophoresis.","date":"1992","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/1370882","citation_count":33,"is_preprint":false},{"pmid":"31258530","id":"PMC_31258530","title":"Extracellular Chromatin Triggers Release of Soluble CEACAM8 Upon Activation of Neutrophils.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31258530","citation_count":29,"is_preprint":false},{"pmid":"31853662","id":"PMC_31853662","title":"High density of CD66b in primary high-grade ovarian cancer independently predicts response to chemotherapy.","date":"2019","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31853662","citation_count":27,"is_preprint":false},{"pmid":"17909799","id":"PMC_17909799","title":"High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias.","date":"2007","source":"Annals of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/17909799","citation_count":25,"is_preprint":false},{"pmid":"10233903","id":"PMC_10233903","title":"Monoclonal Lym-1 antibody-dependent cytolysis by neutrophils exposed to granulocyte-macrophage colony-stimulating factor: intervention of FcgammaRII (CD32), CD11b-CD18 integrins, and CD66b glycoproteins.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10233903","citation_count":25,"is_preprint":false},{"pmid":"32632664","id":"PMC_32632664","title":"CD66b+ monocytes represent a proinflammatory myeloid subpopulation in cancer.","date":"2020","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/32632664","citation_count":22,"is_preprint":false},{"pmid":"32096331","id":"PMC_32096331","title":"CD66b+ neutrophils and α-SMA+ fibroblasts predict clinical outcomes and benefits from postoperative chemotherapy in gastric adenocarcinoma.","date":"2020","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32096331","citation_count":21,"is_preprint":false},{"pmid":"8645267","id":"PMC_8645267","title":"Analysis of heterophilic cell adhesion mediated by CD66b and CD66c using their soluble recombinant proteins.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8645267","citation_count":21,"is_preprint":false},{"pmid":"26176669","id":"PMC_26176669","title":"CD66b Overexpression and Loss of C5a Receptors as Surface Markers for Staphylococcus aureus-Induced Neutrophil Dysfunction.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26176669","citation_count":21,"is_preprint":false},{"pmid":"9427723","id":"PMC_9427723","title":"Mice transgenic for the human CGM6 gene express its product, the granulocyte marker CD66b, exclusively in granulocytes.","date":"1998","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9427723","citation_count":19,"is_preprint":false},{"pmid":"24740105","id":"PMC_24740105","title":"Immunotherapy reduces allergen-mediated CD66b expression and myeloperoxidase levels on human neutrophils from allergic patients.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24740105","citation_count":18,"is_preprint":false},{"pmid":"12383860","id":"PMC_12383860","title":"PACAP enhances the expression of CD11b, CD66b and CD63 in human neutrophils.","date":"2002","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/12383860","citation_count":17,"is_preprint":false},{"pmid":"23686079","id":"PMC_23686079","title":"Fasting glucose level modulates cell surface expression of CD11b and CD66b in granulocytes and monocytes of patients with type 2 diabetes.","date":"2013","source":"Journal of investigative medicine : the official publication of the American Federation for Clinical Research","url":"https://pubmed.ncbi.nlm.nih.gov/23686079","citation_count":15,"is_preprint":false},{"pmid":"36293979","id":"PMC_36293979","title":"Identification of Two Eosinophil Subsets in Induced Sputum from Patients with Allergic Asthma According to CD15 and CD66b Expression.","date":"2022","source":"International journal of environmental research and public health","url":"https://pubmed.ncbi.nlm.nih.gov/36293979","citation_count":13,"is_preprint":false},{"pmid":"12121191","id":"PMC_12121191","title":"Hemin, a heme oxygenase substrate analog, inhibits the cell surface expression of CD11b and CD66b on human neutrophils.","date":"2002","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/12121191","citation_count":13,"is_preprint":false},{"pmid":"12738656","id":"PMC_12738656","title":"Peptidoglycan induces mobilization of the surface marker for activation marker CD66b in human neutrophils but not in eosinophils.","date":"2003","source":"Clinical and diagnostic laboratory immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12738656","citation_count":11,"is_preprint":false},{"pmid":"8776764","id":"PMC_8776764","title":"Preparation and characterization of two human carcinoembryonic antigen family proteins of neutrophils, CD66b and c, in silkworm larvae.","date":"1996","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/8776764","citation_count":9,"is_preprint":false},{"pmid":"39007437","id":"PMC_39007437","title":"CD66b+/CD68+ circulating extracellular vesicles, lactate dehydrogenase and neutrophil-to-lymphocyte ratio can differentiate coronavirus disease 2019 severity during and after infection.","date":"2024","source":"Journal of extracellular vesicles","url":"https://pubmed.ncbi.nlm.nih.gov/39007437","citation_count":6,"is_preprint":false},{"pmid":"36275710","id":"PMC_36275710","title":"\"Rogue\" neutrophil-subset [DEspR+CD11b+/CD66b+] immunotype is an actionable therapeutic target for neutrophilic inflammation-mediated tissue injury - studies in human, macaque and rat LPS-inflammation models.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36275710","citation_count":6,"is_preprint":false},{"pmid":"37232465","id":"PMC_37232465","title":"Relationship Between Infiltration of CD163+ TAMs, FoxP3+ Tregs, or CD66b+ TANs and Cell Differentiation in Colorectal Cancer Tissues.","date":"2023","source":"The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/37232465","citation_count":6,"is_preprint":false},{"pmid":"31170531","id":"PMC_31170531","title":"High CD3+ lymphocytes, low CD66b+ neutrophils, and scarce tumor budding in the invasive front of lip squamous cell carcinomas.","date":"2019","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/31170531","citation_count":5,"is_preprint":false},{"pmid":"40731885","id":"PMC_40731885","title":"CD66b+ Tumor-Infiltrating Neutrophil-like Monocytes as Potential Biomarkers for Clinical Decision-Making in Thyroid Cancer.","date":"2025","source":"Medicina (Kaunas, Lithuania)","url":"https://pubmed.ncbi.nlm.nih.gov/40731885","citation_count":4,"is_preprint":false},{"pmid":"36305130","id":"PMC_36305130","title":"Combinatorial Application of Papain and CD66B for Isolating Glioma- Associated Neutrophils.","date":"2023","source":"Current cancer drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/36305130","citation_count":3,"is_preprint":false},{"pmid":"35600158","id":"PMC_35600158","title":"The correlation between infiltration of FoxP3+ Tregs, CD66b+ TANs and CD163+ TAMs in colorectal cancer.","date":"2022","source":"Central-European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35600158","citation_count":3,"is_preprint":false},{"pmid":"29355143","id":"PMC_29355143","title":"Value of CD16/CD66b/CD45 in comparison to CD55/CD59/CD45 in diagnosis of paroxysmal nocturnal haemoglobinuria: An Indian experience.","date":"2017","source":"The Indian journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/29355143","citation_count":1,"is_preprint":false},{"pmid":"37162631","id":"PMC_37162631","title":"Clinical Significance of CD66b Expression in Non-Small Cell Lung Cancer.","date":"2023","source":"Bulletin of experimental biology and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37162631","citation_count":0,"is_preprint":false},{"pmid":"41244336","id":"PMC_41244336","title":"Ex vivo single-cell profiling of acute myocardial infarction patients reveals disproportionate CD66b+ cell secretion response.","date":"2025","source":"Bioengineering & translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41244336","citation_count":0,"is_preprint":false},{"pmid":"41961692","id":"PMC_41961692","title":"Serum CEACAM6 and CEACAM8 as predictors of poor outcome in pediatric Mycoplasma pneumoniae pneumonia: A single-center prospective cohort study.","date":"2026","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41961692","citation_count":0,"is_preprint":false},{"pmid":"41446068","id":"PMC_41446068","title":"Prolonged Loss of Oxidative Phosphorylation and Mitochondrial Mass Characterize CD66b+ Leukocytes from Patients with Sepsis.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41446068","citation_count":0,"is_preprint":false},{"pmid":"41648617","id":"PMC_41648617","title":"Divergent chromatin remodeling trajectories in CD66b + MDSCs distinguishes recovery from chronic critical illness after sepsis.","date":"2026","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41648617","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.09.05.611350","title":"Inter- and intra-tumor heterogeneous immune presentation in primary uterine carcinosarcoma determined by digital spatial profiling","date":"2024-09-10","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.05.611350","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.09.24310187","title":"NETosis is an important component of chronic inflammation in patients with heart failure","date":"2024-07-10","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.09.24310187","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.06.10.598167","title":"Neutrophil extracellular traps formation and deposition of fibrin and von Willebrand factor during human coronary atherogenesis","date":"2024-06-12","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.10.598167","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":24394,"output_tokens":2932,"usd":0.058581},"stage2":{"model":"claude-opus-4-6","input_tokens":6264,"output_tokens":3063,"usd":0.161843},"total_usd":0.220424,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"CD66b (CEACAM8) antibody binding to neutrophils triggers a transient calcium-dependent activation signal that upregulates CD11/CD18 surface expression and increases neutrophil adhesion to endothelial cells; the signal requires extracellular calcium at or near the time of antibody binding and is blocked by anti-CD18 antibody.\",\n      \"method\": \"Neutrophil adhesion assay to HUVEC monolayers, anti-CD66 mAb stimulation, calcium chelation, flow cytometry\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean functional assay with multiple blocking controls, single lab\",\n      \"pmids\": [\"8699114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CD66b (CGM6) and CD66c (NCA) mediate heterophilic cell adhesion via interaction between their N-terminal domains; deglycosylated forms retain adhesion activity, indicating carbohydrate portions are not required for binding. Primed neutrophil binding to immobilized CD66b or CD66c induces superoxide anion release.\",\n      \"method\": \"Recombinant protein binding assay (CHO transfectants expressing CD66b/CD66c), deglycosylation, N-domain blocking with anti-CD66 mAbs, superoxide assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with recombinant proteins, mutagenesis-equivalent domain blocking, functional readout\",\n      \"pmids\": [\"8645267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CD66b (100 kDa) is identified as a major galectin-3 receptor on neutrophils; it is stored in gelatinase and specific granules of resting neutrophils and mobilized to the cell surface upon activation. Galectin-3 binding activity was demonstrated by affinity chromatography on galectin-3-Sepharose.\",\n      \"method\": \"Galectin-3-Sepharose affinity chromatography of neutrophil granule fractions, immunoblotting, subcellular fractionation, HL-60 differentiation model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — affinity purification from native granules plus functional validation with HL-60 model lacking CD66\",\n      \"pmids\": [\"10553088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CD66b cross-linking on neutrophils induces redistribution and clustering of CD11b (CD11b/CD18) on the neutrophil surface via a lectin-like interaction sensitive to D-mannose inhibition; this CD66b–CD11b/CD18 cooperation is required for GM-CSF/Lym-1-mediated neutrophil cytolytic activity.\",\n      \"method\": \"Immunofluorescence co-staining of CD66b and CD11b after cross-linking, D-mannose inhibition, anti-CD18 blocking, cytolysis assay with blocking antibodies\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct imaging of co-redistribution plus multiple functional blocking experiments, single lab\",\n      \"pmids\": [\"10233903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CEACAM8 (CD66b) exhibits only heterophilic adhesion to CEACAM6, not homophilic adhesion. The N-terminal domain of CEACAM8 on one cell binds the N-domain of CEACAM6 on the opposing cell. Homologue-scanning mutagenesis of CEACAM6 showed that critical adhesion residues for CEACAM6–CEACAM8 heterophilic interaction overlap with but are not identical to those for CEACAM6 homophilic adhesion.\",\n      \"method\": \"CHO transfectants expressing mutant/chimeric CEACAM6 and CEACAM8 proteins, homologue-scanning mutagenesis, cell adhesion assay\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with cell-based adhesion readout, multiple mutants tested\",\n      \"pmids\": [\"11590190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Cross-linking of CD66b on neutrophils induces directed release of preformed interleukin-8 (IL-8) from intracellular storage without de novo cytokine synthesis, in contrast to LPS which induces de novo synthesis.\",\n      \"method\": \"CD66b mAb cross-linking of human neutrophils, intracellular IL-8 detection, comparison with LPS stimulation, ELISA\",\n      \"journal\": \"Human immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD/stimulation with defined phenotypic readout distinguishing two activation modes, single lab\",\n      \"pmids\": [\"17002897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CD66b engagement on eosinophils by mAb or its natural ligand galectin-3 activates the Src kinase family member Hck and induces cellular adhesion, superoxide production, and degranulation. CD66b localizes in lipid rafts; disruption of lipid rafts or removal of the GPI anchor inhibits eosinophil activation. CD66b is constitutively associated with the beta2 integrin CD11b, and CD66b cross-linking induces striking clustering of CD11b.\",\n      \"method\": \"mAb and galectin-3 stimulation of eosinophils, Hck activation assay, lipid raft disruption (methyl-beta-cyclodextrin), GPI anchor removal (PI-PLC), co-immunoprecipitation of CD66b with CD11b, immunofluorescence microscopy\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (co-IP, lipid raft disruption, PI-PLC, kinase assay, imaging) in single study\",\n      \"pmids\": [\"18056392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"CD66b (NCA-95/CGM6) is a GPI-anchored glycoprotein; it is released from the granulocyte cell surface by phosphatidylinositol-specific phospholipase C, confirming GPI anchorage. Its deglycosylated core is ~38 kDa.\",\n      \"method\": \"PI-PLC treatment of granulocytes, SDS-PAGE, immunoblotting with anti-CD67 antibody, deglycosylation\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic GPI cleavage with biochemical confirmation\",\n      \"pmids\": [\"1370882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The CGM6 gene (encoding CD66b/CEACAM8) contains all cis-regulatory elements required for granulocyte-specific expression within a 16.5 kb cosmid region spanning 6 exons; CD66b expression begins in fetal liver at day 12.5 and appears in bone marrow at day 17.5 in transgenic mice, and is exclusive to granulocytes in adult bone marrow and spleen.\",\n      \"method\": \"Transgenic mouse model with human CGM6 cosmid, Northern blot, immunohistochemistry, FACScan analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic model with multiple tissue readouts, single lab\",\n      \"pmids\": [\"9427723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Soluble CEACAM8 (released by granulocytes in response to bacterial DNA via TLR9-dependent signaling) binds to CEACAM1 on pulmonary epithelial cells, leading to tyrosine phosphorylation of the CEACAM1 ITIM, recruitment of the phosphatase SHP-1, and consequent inhibition of TLR2-dependent PI3K-Akt pathway activation and pro-inflammatory responses.\",\n      \"method\": \"CEACAM8-Fc recombinant protein binding to CEACAM1+ epithelial cells, co-IP/pulldown, phospho-ITIM detection, SHP-1 recruitment assay, TLR2 stimulation assay with PI3K-Akt readout, BALF analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — recombinant protein interaction, signaling pathway dissection with ITIM phosphorylation and phosphatase recruitment, in vitro and ex vivo validation\",\n      \"pmids\": [\"24743304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Extracellular chromatin (including mono-nucleosomes and long chromatin fragments) triggers secretion of soluble CEACAM8 by primary human PMN in a time- and concentration-dependent manner, involving both de novo synthesis and degranulation-mediated release; CEACAM8 was also detected at high concentration in synovial fluid of RA patients.\",\n      \"method\": \"Primary human PMN stimulation with chromatin/nucleosomes, ELISA for soluble CEACAM8, inhibitor studies distinguishing synthesis vs. degranulation, synovial fluid analysis\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct stimulation with natural ligand, two mechanistic pathways distinguished, single lab\",\n      \"pmids\": [\"31258530\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CEACAM8 (CD66b) is a GPI-anchored, granulocyte-specific glycoprotein stored in specific and gelatinase granules that, upon mobilization to the cell surface, functions as a galectin-3 receptor and heterophilic adhesion molecule (binding CEACAM6 via N-domain interactions); its engagement activates Src-family kinase Hck, induces CD11b clustering through constitutive physical association, triggers calcium-dependent upregulation of CD11/CD18-mediated adhesion, and drives degranulation including release of preformed IL-8; in its soluble secreted form (released via TLR9-dependent signaling or in response to extracellular chromatin), CEACAM8 binds CEACAM1 on epithelial cells, phosphorylates the CEACAM1 ITIM, recruits SHP-1, and dampens TLR2-dependent PI3K-Akt pro-inflammatory signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CEACAM8 (CD66b) is a GPI-anchored, granulocyte-specific glycoprotein that functions as both a cell-surface adhesion/activation receptor and a soluble anti-inflammatory mediator. Stored in specific and gelatinase granules of resting neutrophils, CEACAM8 is mobilized to the cell surface upon activation, where it serves as a galectin-3 receptor and mediates heterophilic adhesion with CEACAM6 through N-terminal domain interactions; its cross-linking activates the Src-family kinase Hck within lipid rafts, induces clustering of the constitutively associated β2-integrin CD11b/CD18, triggers calcium-dependent upregulation of integrin-mediated adhesion, superoxide production, degranulation, and directed release of preformed IL-8 [PMID:8699114, PMID:8645267, PMID:10553088, PMID:11590190, PMID:18056392, PMID:17002897]. In its soluble form, released via TLR9-dependent signaling in response to bacterial DNA or extracellular chromatin, CEACAM8 binds CEACAM1 on pulmonary epithelial cells, phosphorylates the CEACAM1 ITIM, recruits the phosphatase SHP-1, and thereby dampens TLR2-dependent PI3K-Akt pro-inflammatory signaling [PMID:24743304, PMID:31258530]. Granulocyte-restricted expression is directed by cis-regulatory elements within the CGM6 locus, with expression initiating in fetal liver hematopoiesis [PMID:9427723].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Establishing that CEACAM8 is GPI-anchored resolved how a CEA-family member lacking a transmembrane domain is tethered to the granulocyte surface and set the stage for understanding its signaling through lipid-raft-associated partners rather than an intrinsic cytoplasmic tail.\",\n      \"evidence\": \"PI-PLC cleavage from granulocytes with SDS-PAGE/immunoblot confirmation of released ~38 kDa deglycosylated core\",\n      \"pmids\": [\"1370882\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which a GPI-anchored protein without a cytoplasmic domain transduces signals was unknown\",\n        \"Whether GPI anchorage was required for function in vivo was untested\"\n      ]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Demonstrating that CEACAM8 engagement triggers calcium-dependent upregulation of CD11/CD18-mediated neutrophil adhesion to endothelium, and that CEACAM8 mediates heterophilic binding with CEACAM6 via N-terminal domains, established its dual role as an adhesion molecule and activation receptor on granulocytes.\",\n      \"evidence\": \"Anti-CD66b mAb stimulation of neutrophils with HUVEC adhesion assay plus calcium chelation/CD18 blocking; recombinant protein binding assays with CHO transfectants and N-domain blocking antibodies\",\n      \"pmids\": [\"8699114\", \"8645267\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The downstream kinase signaling pathway was unidentified\",\n        \"Physical association between CEACAM8 and integrins was not yet demonstrated\"\n      ]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identifying that all cis-regulatory elements for granulocyte-restricted expression reside within a 16.5 kb CGM6 cosmid explained the lineage-specific expression pattern and showed that CEACAM8 expression begins during fetal hematopoiesis.\",\n      \"evidence\": \"Transgenic mice carrying human CGM6 cosmid, with Northern blot, immunohistochemistry, and FACS confirming granulocyte-restricted expression from fetal day 12.5\",\n      \"pmids\": [\"9427723\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific transcription factors driving granulocyte-restricted expression were not identified\",\n        \"Regulatory elements were not mapped to individual promoter/enhancer regions\"\n      ]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identifying CEACAM8 as a major galectin-3 receptor stored in gelatinase and specific granules, and showing that its cross-linking induces CD11b clustering via a mannose-sensitive lectin-like interaction, connected granule mobilization to integrin-dependent effector functions.\",\n      \"evidence\": \"Galectin-3-Sepharose affinity chromatography of neutrophil granule fractions; immunofluorescence of CD66b/CD11b co-redistribution after cross-linking with D-mannose inhibition\",\n      \"pmids\": [\"10553088\", \"10233903\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether galectin-3 binding directly triggers CD11b clustering or acts through an intermediate was unclear\",\n        \"Nature of the CD66b–CD11b physical interaction was unresolved\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Systematic mutagenesis established that CEACAM8 engages exclusively in heterophilic (not homophilic) adhesion with CEACAM6, with critical contact residues in the N-domain overlapping but distinct from those used in CEACAM6 homophilic binding, defining the structural basis of selectivity.\",\n      \"evidence\": \"Homologue-scanning mutagenesis of CEACAM6 in CHO transfectants paired with CEACAM8-expressing cells in cell adhesion assays\",\n      \"pmids\": [\"11590190\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No crystal structure of the CEACAM8–CEACAM6 N-domain complex\",\n        \"Functional consequence of heterophilic vs. homophilic preference in vivo was untested\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showing that CEACAM8 cross-linking triggers directed release of preformed IL-8 without de novo synthesis revealed a rapid, degranulation-coupled cytokine mobilization pathway distinct from transcription-dependent inflammatory responses.\",\n      \"evidence\": \"CD66b mAb cross-linking of human neutrophils with intracellular IL-8 detection by ELISA, compared to LPS-induced de novo synthesis\",\n      \"pmids\": [\"17002897\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Signaling intermediates linking CD66b engagement to IL-8 granule exocytosis were not identified\",\n        \"Whether this pathway operates in vivo during infection was untested\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating that CEACAM8 resides in lipid rafts, is constitutively associated with CD11b, and signals through Hck upon engagement by galectin-3 provided the missing signaling mechanism for a GPI-anchored protein lacking an intrinsic cytoplasmic domain.\",\n      \"evidence\": \"Co-immunoprecipitation of CD66b with CD11b, Hck kinase activation assay, lipid raft disruption with methyl-β-cyclodextrin, GPI removal by PI-PLC, immunofluorescence in eosinophils\",\n      \"pmids\": [\"18056392\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether Hck activation is direct or requires an adaptor bridging CD66b to intracellular kinases was unresolved\",\n        \"Structural basis of the constitutive CD66b–CD11b association was unknown\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovering that soluble CEACAM8 binds epithelial CEACAM1, phosphorylates its ITIM, recruits SHP-1, and suppresses TLR2-PI3K-Akt signaling established a granulocyte-derived anti-inflammatory paracrine circuit—the first defined function for the secreted form of CEACAM8.\",\n      \"evidence\": \"CEACAM8-Fc binding to CEACAM1+ epithelial cells, co-IP for SHP-1 recruitment, phospho-ITIM detection, TLR2/PI3K-Akt pathway analysis, BALF validation\",\n      \"pmids\": [\"24743304\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether soluble CEACAM8 binds CEACAM1 in the same N-domain orientation as cell-surface heterophilic interactions was unknown\",\n        \"In vivo relevance of this anti-inflammatory circuit in infection resolution was not tested in animal models\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identifying extracellular chromatin as a stimulus for soluble CEACAM8 secretion (via both degranulation and de novo synthesis) linked sterile inflammation and NETosis to the CEACAM8-mediated anti-inflammatory pathway, and elevated synovial fluid levels in RA patients implied clinical relevance.\",\n      \"evidence\": \"Primary PMN stimulation with mono-nucleosomes and long chromatin, ELISA, inhibitor dissection of synthesis vs. degranulation, RA synovial fluid analysis\",\n      \"pmids\": [\"31258530\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Receptor or sensor on neutrophils mediating chromatin-induced CEACAM8 release was not identified\",\n        \"Whether elevated soluble CEACAM8 in RA fluid is protective or a disease biomarker was not established\",\n        \"Single-lab finding; independent replication of chromatin-triggered secretion pathway needed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of the CEACAM8–CD11b constitutive complex, the adaptor mechanism linking GPI-anchored CEACAM8 to Hck activation, the in vivo role of the soluble CEACAM8–CEACAM1 anti-inflammatory axis during infection, and the chromatin-sensing pathway that triggers CEACAM8 release.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model of the CEACAM8–CD11b or CEACAM8–CEACAM6 complex\",\n        \"No genetic loss-of-function model (CEACAM8 is absent in rodents except as a transgene)\",\n        \"Adaptor linking GPI-anchored CEACAM8 to intracellular kinase Hck is unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 6, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 6, 7]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [9, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 5, 6, 9]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 9]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [1, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CEACAM6\",\n      \"CEACAM1\",\n      \"LGALS3\",\n      \"ITGAM\",\n      \"HCK\",\n      \"PTPN6\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}